NYXOID

This brand name is authorized in Australia, Austria, Croatia, Estonia, Ireland, Italy, Lithuania, New Zealand, Poland, Romania, UK.

Active ingredients

The drug NYXOID contains one active pharmaceutical ingredient (API):

1
UNII 5Q187997EE - NALOXONE HYDROCHLORIDE DIHYDRATE
 

Naloxone hydrochloride, a semisynthetic morphine derivative (N-allyl-nor-oxymorphone), is a specific opioid antagonist that acts competitively at opioid receptors. It reveals very high affinity for the opioid receptor sites and therefore displaces both opioid agonists and partial antagonists, such as pentazocine, for example, but also nalorphine.

 
Read more about Naloxone

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 NYXOID Nasal spray MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V03AB15 Naloxone V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 11816X, 11817Y
EE Ravimiamet 1756773
GB Medicines & Healthcare Products Regulatory Agency 357442
IT Agenzia del Farmaco 045777012
LT Valstybinė vaistų kontrolės tarnyba 1084451
NZ Medicines and Medical Devices Safety Authority 20367, 21656
PL Rejestru Produktów Leczniczych 100399996
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W66685001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.